IPP Bureau
Abbott India posts Q4 FY25 net profit at Rs. 367.04 Cr
By IPP Bureau - May 18, 2025
The company has posted net profit of Rs. 1,414.44 crores for the Financial Year ended March 31, 2025
Wanbury posts Q4 FY25 consolidated PAT at Rs. 20.25 Cr
By IPP Bureau - May 18, 2025
The company has posted net profit of Rs. 30.53 crores for the Financial Year ended March 31, 2025
Solara Active Pharma Sciences posts Q4 FY25 consolidated loss at Rs. 2.10 Cr
By IPP Bureau - May 18, 2025
The company has posted net profit of Rs. 0.54 crores for the Financial Year ended March 31, 2025
Neuland Laboratories posts Q4 FY25 consolidated PAT at Rs. 27.80 Cr
By IPP Bureau - May 18, 2025
The company has posted net profit of Rs. 260.10 crores for the Financial Year ended March 31, 2025
IOL Chemicals and Pharmaceuticals posts Q4 FY25 PAT at Rs. 31.42 Cr
By IPP Bureau - May 17, 2025
IOL Chemicals and Pharmaceuticals has posted net profit of Rs.101.07 crores for the Financial Year ended March 31, 2025
Jubilant Pharmova posts Q4 FY25 consolidated PAT at Rs. 153.6 Cr
By IPP Bureau - May 17, 2025
Jubilant Pharmova has posted net profit of Rs. 839.4 crores for the Financial Year ended March 31, 2025
JB Pharma records revenue growth of 10% to Rs. 949 crore in Q4 FY25
By IPP Bureau - May 16, 2025
Net Profit increased by 15% to Rs. 146 crores in Q4 FY25 and 19% to Rs. 660 crores in FY25
Shelter Pharma launches three new products
By IPP Bureau - May 16, 2025
Shelter Pharma Limited is set to capitalize on the growing demand for natural health products in India
Remedium Lifecare secures Rs. 182.7 crore export deal
By IPP Bureau - May 16, 2025
The CDMO upgrade represents a transformational step for Remedium Lifecare
Lupin posts consolidated Q4 FY25 PAT at Rs. 772.52 Cr
By IPP Bureau - May 16, 2025
Piramal Pharma reports Q4 FY25 consolidated net profit of Rs. 153.50 Cr
By IPP Bureau - May 16, 2025
The company has posted net profit of Rs. 91.13 crores for the Financial Year ended March 31, 2025
Sanofi India posts 27% growth in operating profits in Q1 2025
By IPP Bureau - May 16, 2025
Standalone profit from operations for the quarter were Rs. 162 crores
Emcutix launches urea-based skin-care moisturizers ‘Ureaderm'
By IPP Bureau - May 14, 2025
Ideal for extreme dry skin and hyperkeratotic conditions such as psoriasis and ichthyosis, Ureaderm offers the next step in evidence-based, effective skin hydration
Biocon Q4 FY25 consolidated PAT jumps 153% to Rs. 344 Cr
By IPP Bureau - May 14, 2025
For the full financial year FY25, revenue from operations grew 9 per cent to Rs. 11,537.8 crore, compared to Rs. 10,588 crore in FY24.
